drugset / Trial / NCT01429870

Steroids Added to Dithranol and Narrow Band UVB(Ultraviolet B) (UVBnb) in Psoriasis

NCT01429870

Phase 4 Withdrawn University of Zurich
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Objective(s): (i) To assess the effect of adjunctive topical steroids in the combined treatment with UVBnb and dithranol on the remission time after therapy till a relapse of psoriasis defined as 50% loss of PASI (Psoriasis Area and Severity Index) improvement obtained through the antecedent treatment. (ii) To assess the impact of adjuvant topical steroids in the combined treatment with UVBnb and dithranol on the clearing time of psoriasis lesions under therapy (PASI 75). * Trial with medicinal product

Timeline

Start
2011-08
Primary completion
2016-08
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Triamcinolone Other / unclassified 0.1 % Topical

Indications